Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2037431
Max Phase: Preclinical
Molecular Formula: C21H24ClN3S
Molecular Weight: 385.96
Molecule Type: Small molecule
Associated Items:
ID: ALA2037431
Max Phase: Preclinical
Molecular Formula: C21H24ClN3S
Molecular Weight: 385.96
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
Standard InChI: InChI=1S/C21H24ClN3S/c22-17-8-10-18(11-9-17)25-15-13-24(14-16-25)12-4-3-7-21-23-19-5-1-2-6-20(19)26-21/h1-2,5-6,8-11H,3-4,7,12-16H2
Standard InChI Key: SCUPEGWTGGLXHI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 385.96 | Molecular Weight (Monoisotopic): 385.1379 | AlogP: 5.09 | #Rotatable Bonds: 6 |
Polar Surface Area: 19.37 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 7.85 | CX LogP: 5.44 | CX LogD: 4.86 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -2.16 |
1. Zhu XY, Etukala JR, Eyunni SV, Setola V, Roth BL, Ablordeppey SY.. (2012) Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants., 53 [PMID:22520153] [10.1016/j.ejmech.2012.03.042] |
2. Sampson D, Zhu XY, Eyunni SV, Etukala JR, Ofori E, Bricker B, Lamango NS, Setola V, Roth BL, Ablordeppey SY.. (2014) Identification of a new selective dopamine D4 receptor ligand., 22 (12): [PMID:24800940] [10.1016/j.bmc.2014.04.026] |
Source(1):